Clinical cardiac manifestations of HIV infection: A review of current literature

Wisconsin Medical Journal

Volumn 101, Issue 7, 2002, Pages 40-45+39

  Chu, William W ^a   Sosman, James M ^a   Stein, James H ^a  

^a Section of Cardiovascular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; COTRIMOXAZOLE; DIDANOSINE; DOXORUBICIN; FOSCARNET; GANCICLOVIR; PENTAMIDINE; PROTEINASE INHIBITOR; PYRIMETHAMINE; ZIDOVUDINE;

BRADYCARDIA; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; DYSPNEA; HEART CARCINOMA; HEART DILATATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INSULIN RESISTANCE; MYOCARDITIS; PREVALENCE; PULMONARY HYPERTENSION; REVIEW; SURVIVAL RATE; TORSADE DES POINTES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOVASCULAR DISEASES; HIV INFECTIONS; HUMANS; PREVALENCE; RISK FACTORS;

EID: 0036029648     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Sepkowitz, KA. AIDS - The first 20 years. N Engl J Med. 2001;344:1764-1772.
2. HIV/AIDS Surveillance Report from Center for Disease Control, Volume 12, Number 1, 2000.
3. Wisconsin HIV/AIDS Quality Surveillance Survey Through June 30, 2001. Wisconsin Department of Health and Family Services.
4. Antran BR, Gorin I, Lerbowitch M. AIDS in a Haitian woman with cardiac Kaposi's sarcoma and Whipple's disease. Lancet. 1983;1:767-768.
5. Milei J, Grana, D, Alonso GF, Matturi L. Cardiac involvement in the Acquired Immunodeficiency Syndrome-a review to push action. Committee for the study of cardiac involvement in AIDS. Clin Cardio. I 1998;21:465-472.
6. Yunis NA, Stone VE. Cardiac manifestations of HIV/AIDS. J AIDS Hum Retrov. 1998;18:145-154.
7. Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: A review of pericardial disease in patients with HIV infection. Mount Sinai J Med. 1998;65:33-39.
8. Heidenreich PA, Eisenberg MJ, Kee LL, et al. Pericardial effusion in AIDS. Incidence and survival. Circulation. 1995;92:3229-3234.
9. Currie PF, Jacob AJ, Foreman AR, et al. Heart muscle disease related to HIV infection: Prognostic implications. BMJ. 1994;309:1605-1607.
10. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med. 2000;160:602-608.
11. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol. 1993;71:955-958.
12. Fath-Ordoubadi F, van der Watt MJ, Noble MIM. Early presentation of dilated cardiomyopathy as a part of seroconversion illness in human immunodeficiency virus infection. Clin Cardio. I 1997;20:738-739.
13. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol 1990;66:203-206.
14. Jacob AJ, Sutherland GR, Bird AG, Brettle RP, Ludlam CA, et al. Myocardial dysfunction in patients infected with HIV: Prevalence and risk factors. Br Heart J. 1992;68:549-553.
15. Patel RC, Frishman WH. AIDS and the heart: Clinicopathologic assessment. Cardiovasc Pathol. 1995;4:173-183.
16. Currie PF, Jacobs AJ, Foremann AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV infection: Prognostic implications. BMJ. 1994;309:1605-1607.
17. Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquired immune deficiency syndrome: A 1991 update. Am Heart J. 1991;122:535-544.
18. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodeficiency virus infection and pulmonary hypertension: Two new cases and a review of 86 reported cases. Mayo Clin Proc. 1998;73:37-45.
19. Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation. 1994;89:2722-2727.
20. Mary-Krause M, Cotter L, Partisani M, Simon A, Costagliola D. Impact of treatment with protease inhibitors on myocardial infarction occurrence in HIV-infected men. Eighth Conference on Retroviruses and Opportunistic Infection, 2001, abstract 657.
21. Klein D, Hurley L, Sorel M, Sidney S. Do protease inhibitors increase risk for coronary heart disease among HIV positive patients - Follow-up through June 2000. Eighth Conference on Retroviruses and Opportunistic Infections, 2001, abstract 655.
22. Tabib A, Greenland T, Mercier I, Loire R, Mornex JF. Coronary lesions in young HIV-positive subjects at necropsy. Lancet. 1992;340:730.
23. De Lorgeril M, Boissonnat P, Dureau G, Renaud S. HIV infection and immune system in genesis of coronary lesions. Lancet. 1992;340:1226-1227.
24. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab. 1993;76:1423-1427.
25. Stein JH, Klein MA, Bellehumeur JL, Aeschlimann SE, McBride PE, Sosman JM. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation. 2001;104:257-262.
26. Dube MP, Sprecher D, Henry WK, et al. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the adult AIDS clinical trial group cardiovascular disease focus group. Clin Infect Dis. 2000;31:1216-1224.
27. Aboulafia DM, Bush R, Picozzi VJ. Cardiac tamponade due to primary pericardial lymphoma in a patient with AIDS. Chest. 1994;106:1295-1299.